Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A-36A. https://doi.org/10.1155/2005/269076.

Article  PubMed  Google Scholar 

Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen County from 1962 to 1987. Scand J Gastroenterol. 1991;26:1247–1256. https://doi.org/10.3109/00365529108998621.

Article  PubMed  CAS  Google Scholar 

Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci. 1993;38:1137–1146. https://doi.org/10.1007/BF01295733.

Article  PubMed  CAS  Google Scholar 

Ungro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756–1770. https://doi.org/10.1016/S0140-6736(16)32126-2.

Article  Google Scholar 

Roda G, Narula N, Pinotti R et al. Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Aliment Pharmacol Ther. 2017;45:1481–1492. https://doi.org/10.1111/apt.14063.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ng SC, Zeng Z, Niewiadomski O et al. Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia. Gastroenterology. 2016;150:86–95. https://doi.org/10.1053/j.gastro.2015.09.005.

Article  PubMed  Google Scholar 

Rönnblom A, Samuelsson SM, Ekbom A. Ulcerative colitis in the county of Uppsala 1945–2007: incidence and clinical characteristics. J Crohns Colitis. 2010;4:532–536. https://doi.org/10.1016/j.crohns.2010.03.003.

Article  PubMed  Google Scholar 

Sjöberg D, Holmström T, Larsson M et al. Incidence and natural history of ulcerative colitis in the Uppsala region of Sweden 2005–2009—results from the IBD Cohort of the Uppsala Region (ICURE). J Crohns Colitis. 2013;7:e351–e357. https://doi.org/10.1016/j.crohns.2013.02.006.

Article  PubMed  Google Scholar 

Vester-Andersen MK, Vind I, Prosberg MV et al. Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003–2011—a Danish population-based cohort study. J Crohns Colitis. 2014;8:1675–1683. https://doi.org/10.1016/j.crohns.2014.07.010.

Article  PubMed  Google Scholar 

Höie O, Wolters FL, Riis L et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol. 2007;102:1692–1701. https://doi.org/10.1111/j.1572-0241.2007.01265.x.

Article  PubMed  Google Scholar 

Meucci G, Vecchi M, Astegiano M et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol. 2000;95:469–473. https://doi.org/10.1111/j.1572-0241.2000.t01-1-01770.x.

Article  PubMed  CAS  Google Scholar 

Magro F, Gionchettti P, Eliakim R et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649–670. https://doi.org/10.1093/ecco-jcc/jjx008.

Article  PubMed  Google Scholar 

Magro F, Rodrigues A, Vieira AI et al. Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflamm Bowel Dis. 2012;18:573–583. https://doi.org/10.1002/ibd.21815.

Article  PubMed  Google Scholar 

Kim B, Park SJ, Hong SP et al. Proximal disease extension and related predicting factors in ulcerative proctitis. Scand J Gastroenterol. 2014;49:177–183. https://doi.org/10.3109/00365521.2013.867360.

Article  PubMed  Google Scholar 

Sahami S, Konte K, Buskens CJ et al. Risk factors for proximal disease extension and colectomy in left-sided ulcerative colitis. United Eur Gastroenterol J. 2017;5:554–562. https://doi.org/10.1177/2050640616679552.

Article  CAS  Google Scholar 

Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J Med. 1987;317:1625–1629. https://doi.org/10.1056/NEJM198712243172603.

Article  PubMed  CAS  Google Scholar 

Park SH, Yang SK, Park SK et al. Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare. Can J Gastroenterol Hepatol. 2014;28:125–130. https://doi.org/10.1155/2014/834512.

Article  PubMed  PubMed Central  Google Scholar 

Peyrin-Biroulet L, Sandborn W, Sands BE et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324–1338. https://doi.org/10.1038/ajg.2015.233.

Article  PubMed  CAS  Google Scholar 

Dignass A, Eliakim R, Magro F et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965–990. https://doi.org/10.1016/j.crohns.2012.09.003.

Article  PubMed  Google Scholar 

Harbord M, Annese V, Vavricka SR et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:239–254. https://doi.org/10.1093/ecco-jcc/jjv213.

Article  PubMed  Google Scholar 

Walsh E, Chah YW, Chin SM et al. Clinical predictors and natural history of disease extension in patients with ulcerative proctitis. Inflamm Bowel Dis. 2017;23:2035–2041. https://doi.org/10.1097/MIB.0000000000001214.

Article  PubMed  Google Scholar 

Etchevers MJ, Aceituno M, García-Bosch O et al. Risk factors and characteristics of extent progression in ulcerative colitis. Inflamm Bowel Dis. 2009;15:1320–1325. https://doi.org/10.1002/ibd.20897.

Article  PubMed  Google Scholar 

Bertani L, Bodini G, Mumolo MG et al. Corticosteroid treatment at diagnosis: an analysis of relapses, disease extension, and colectomy rate in ulcerative colitis. Dig Dis Sci. 2020;65:2397–2402. https://doi.org/10.1007/s10620-019-05959-y.

Article  PubMed  CAS  Google Scholar 

Burisch J, Ungaro R, Vind I et al. Proximal disease extension in patients with limited ulcerative colitis: a Danish population-based inception cohort. J Crohns Colitis. 2017;11:1200–1204. https://doi.org/10.1093/ecco-jcc/jjx066.

Article  PubMed  PubMed Central  Google Scholar 

Anzai H, Hata K, Kishikawa J et al. Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis. Colorectal Dis. 2016;18:O278–O282. https://doi.org/10.1111/codi.13435.

Article  PubMed  CAS  Google Scholar 

Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–458. https://doi.org/10.1038/bmt.2012.244.

Article  PubMed  CAS  Google Scholar 

Henriksen M, Jahnsen J, Lygren I et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12:543–550. https://doi.org/10.1097/01.MIB.0000225339.91484.fc.

Article  PubMed  Google Scholar 

Romberg-Camps MJ, Dagnelie PC, Kester AD et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009;104:371–383. https://doi.org/10.1038/ajg.2008.38.

Article  PubMed  CAS  Google Scholar 

Soberg IC, Lygren I, Jahnsen J et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431–440. https://doi.org/10.1080/00365520802600961.

Article  Google Scholar 

Stewénius J, Adnerhill I, Ekelund GR et al. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis Colon Rectum. 1996;39:1019–1025. https://doi.org/10.1007/BF02054693.

Article  PubMed